GeneDx Holdings Integrates Genetic Testing with Epic's Aura for Enhanced Healthcare Diagnostics

GeneDx Enhances Genetic Testing Through Epic's Aura Integration

GeneDx Holdings, a prominent player in genomic insights, has recently launched its services on Epic’s specialty diagnostics platform, Aura. This integration marks a significant advancement in how healthcare providers manage genetic testing within electronic health records (EHR). By enabling seamless ordering and results retrieval for a range of diagnostic tests—including exome sequencing (ES), whole genome sequencing (WGS), and rapid whole genome sequencing (rWGS)—GeneDx aims to enhance the efficiency and accuracy of genetic diagnostics. The first health system to adopt this integration is UNC Health, which underscores the growing trend of embedding advanced genetic insights into everyday clinical practice.

The integration of GeneDx’s services within the Aura platform allows healthcare professionals to access genetic test results alongside other laboratory data. This holistic view plays a crucial role in improving the visibility of genetic information, which is essential for accurate diagnosis and treatment planning. Dr. Michael Adams from UNC Health emphasizes that this approach not only facilitates better research outcomes but also drives quality improvements in patient care. By streamlining the genetic testing process, GeneDx and Epic enhance the clinician's ability to diagnose genetic conditions, ultimately leading to faster treatment timelines and improved patient outcomes.

Katherine Stueland, President and CEO of GeneDx, reaffirms the company’s commitment to patient-centered solutions. With 80% of genetics experts reportedly relying on GeneDx for their testing needs, the company has built a reputation for delivering valuable genomic insights. The integration with Epic’s Aura platform is anticipated to expand its reach, as more health systems recognize the importance of incorporating genetic testing into routine care across various medical specialties, including pediatrics and genetics. With a robust history of sequencing over 750,000 exomes and genomes, GeneDx is well-positioned to leverage one of the largest rare disease datasets in the genomic testing field.

As GeneDx continues to evolve its services, the integration with Epic Aura represents a pivotal moment in the genomic testing landscape. This collaboration not only enhances accessibility to genetic insights but also reinforces the importance of genomics in modern healthcare. Interested parties can find additional information about this integration on GeneDx’s dedicated website, highlighting the company’s proactive approach to advancing genetic testing within health systems.

In summary, the integration of GeneDx’s services with Epic's Aura platform is a transformative step for genomic testing in healthcare, fostering improved diagnostics and patient care. As more health systems adopt this integration, the implications for enhanced clinical practices and patient outcomes become increasingly significant.